Rhenman & Partners Asset Management Ab Stereotaxis, Inc. Transaction History

Rhenman & Partners Asset Management Ab

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$1.85 - $2.71 $561,867 - $823,059	-303,712 Reduced 38.09%	493,618 $1.01 Million
Q1 2022 May 13, 2022	SELL	$3.11 - $6.63 $8,303 - $17,702	-2,670 Reduced 0.33%	797,330 $2.97 Million
Q3 2021 Nov 12, 2021	BUY	$5.34 - $9.87 $617,293 - $1.14 Million	115,598 Added 16.89%	800,000 $4.3 Million
Q1 2021 May 14, 2021	BUY	$4.43 - $7.95 $531,608 - $954,015	120,002 Added 21.26%	684,402 $4.6 Million
Q4 2020 Jan 19, 2021	BUY	$3.11 - $5.3 $1.76 Million - $2.99 Million	564,400 New	564,400 $2.87 Million

41.1M

413K

26.3K

Ticker STXS
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,790,096
Market Cap $145M
Description
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.